Pinto Joshua
- SEC CIK
- 0001992595
In the past year, 1 open-market sale filing worth $21.1K and no purchases.
Current role at each company
- NMRA Neumora Therapeutics, Inc.President & CEOas of Aug 21, 2026
- MTSR Metsera, Inc.Directoras of Nov 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $21.1K
- 1 filing
- Net
- −$21.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pinto Joshua as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NMRA Neumora Therapeutics, Inc.
President & CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Pinto JoshuaPresident | SSale | −5.97K | $3.54 | −$21.1K | −9.4%57.8K after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Pinto JoshuaPresident | SSale | −8.05K | $1.67 | −$13.4K | −9.5%77.0K after | 10b5-1 |
| Aug 27, 2024 (view filing) | Aug 27 | Same day | Pinto JoshuaChief Financial Officer | SSale | −15.7K | $11.39 | −$178.7K | −10.1%139.0K after | 10b5-1 |
| Aug 26, 2024 (view filing) | Aug 22-26 | 4 days | Pinto JoshuaChief Financial Officer | SSale | −84.3K | $11.67 | −$984.3K | −35.3%154.7K after | 3 lots10b5-1 |